Therini Bio
Therini Bio is developing novel therapeutics based insights into the role of fibrin in driving chronic innate immune activation.
$39M Series A ·
Source: Ophthalmology Times
Latest round on record: Series A, May 2026, amount undisclosed.
Total raised: $56M across 2 sourced rounds
All 3 rounds ↓Signals
Therini Bio | 535 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | undisclosed | — | fundraisingfox.com | |
| Series A | $39M | — | Ophthalmology Times | |
| Seed | $17M | prnewswire.com |
Timeline
- Website created
Founders and team
KA
Katerina Akassoglou Founder and Scientific AdvisorLinkedIn · source: therinibio.comDB
Dan Burgess CEO
Investors
AAngelini Ventures
AApollo Health Ventures
DDementia Discovery Fund
DDolby Family Ventures
EEli Lilly
FFoundation for a Better World
MMRL Ventures Fundlead investor
SSanofi Ventureslead investor
SSV Health Investorslead investor
Companies like Therini Bio
FFreya BiosciencesSeries A · Nov 2024
MMatchpoint Therapeutics$150M Series B+ · Oct 2026
NNormunity$75M Series B+ · Jan 2025
OOuro Medicines$120M Series A · Jan 2025
FFlip TherapeuticsSeed · Sep 2026
HHoloclara$16M Series A · Jun 2024
Other companies backed by MRL Ventures Fund
LLifeMine Therapeutics$75M Series B+ · Aug 2026
AATB Therapeutics$57M Series A · Dec 2024
HHotSpot Therapeutics$100M Series B+ · Nov 2021
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/therini-bio (get a free API key).